ARTICLE | Company News
Activaero, Chiesi deal
September 16, 2013 7:00 AM UTC
The companies partnered to evaluate a drug-device combination product using Activaero's Flow and Volume Controlled Inhalation Technology (FAVORITE) and Chiesi's Bethkis inhaled tobramycin solution to...